Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 3
2009 1
2010 2
2011 1
2012 1
2013 2
2014 5
2015 6
2016 2
2017 3
2018 6
2019 8
2020 7
2021 9
2022 10
2023 7
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Obesity and type 2 diabetes: Also linked in therapeutic options.
Rubio-Almanza M, Cámara-Gómez R, Merino-Torres JF. Rubio-Almanza M, et al. Among authors: merino torres jf. Endocrinol Diabetes Nutr (Engl Ed). 2019 Mar;66(3):140-149. doi: 10.1016/j.endinu.2018.08.003. Epub 2018 Oct 15. Endocrinol Diabetes Nutr (Engl Ed). 2019. PMID: 30337188 Review. English, Spanish.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Free article. Clinical Trial.
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM; SELECT Trial Investigators. Deanfield J, et al. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3. Lancet. 2024. PMID: 39181597 Free article. Clinical Trial.
Nutritional Assessment in Outpatients with Heart Failure.
López Guillén R, Argente Pla M, Micó García A, Dura de Miguel Á, Gascó Santana E, Martín Sanchis S, Merino Torres JF. López Guillén R, et al. Among authors: merino torres jf. Nutrients. 2024 Aug 26;16(17):2853. doi: 10.3390/nu16172853. Nutrients. 2024. PMID: 39275170 Free PMC article.
Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.
García de Lucas MD, Caballero I, Fernández-García JC, Domínguez-Rodríguez M, Moreno-Moreno P, Jiménez-Millán A, Botana-López M, Avilés B, Merino-Torres JF, Soto A, Tejera C, Morales C. García de Lucas MD, et al. Among authors: merino torres jf. Front Endocrinol (Lausanne). 2023 Oct 24;14:1240279. doi: 10.3389/fendo.2023.1240279. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37955013 Free PMC article.
Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods.
Drachenberg CB, Buettner-Herold M, Aguiar PV, Horsfield C, Mikhailov AV, Papadimitriou JC, Seshan SV, Perosa M, Boggi U, Uva P, Rickels M, Grzyb K, Arend L, Cuatrecasas M, Toniolo MF, Farris AB, Renaudin K, Zhang L, Roufousse C, Gruessner A, Gruessner R, Kandaswamy R, White S, Burke G, Cantarovich D, Parsons RF, Cooper M, Kudva YC, Kukla A, Haririan A, Parajuli S, Merino-Torres JF, Argente-Pla M, Meier R, Dunn T, Ugarte R, Rao JS, Vistoli F, Stratta R, Odorico J. Drachenberg CB, et al. Among authors: merino torres jf. Am J Transplant. 2024 Mar;24(3):362-379. doi: 10.1016/j.ajt.2023.10.011. Epub 2023 Oct 21. Am J Transplant. 2024. PMID: 37871799 Free article.
Surgical and Pharmacological Management of Functioning Pheochromocytoma and Paraganglioma.
García MIDO, Palasí R, Gómez RC, Marco JLP, Merino-Torres JF. García MIDO, et al. Among authors: merino torres jf. In: Mariani-Costantini R, editor. Paraganglioma: A Multidisciplinary Approach [Internet]. Brisbane (AU): Codon Publications; 2019 Jul 2. Chapter 4. In: Mariani-Costantini R, editor. Paraganglioma: A Multidisciplinary Approach [Internet]. Brisbane (AU): Codon Publications; 2019 Jul 2. Chapter 4. PMID: 31294943 Free Books & Documents. Review.
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.
Durán-Martínez M, Azriel S, Doulatram-Gamgaram VK, Moreno-Pérez Ó, Pinés-Corrales PJ, Tejera-Pérez C, Merino-Torres JF, Brito-Sanfiel M, Chico A, Marco A, García-Fernández E, Martínez-Montoro JI; Diabetes Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Durán-Martínez M, et al. Among authors: merino torres jf. Diabetes Metab. 2024 Jan;50(1):101501. doi: 10.1016/j.diabet.2023.101501. Epub 2023 Dec 5. Diabetes Metab. 2024. PMID: 38061425 Free article.
74 results